Literature DB >> 12480264

Involvement of plasmacytoid dendritic cells in human diseases.

Frode L Jahnsen1, Lorant Farkas, Fridtjof Lund-Johansen, Per Brandtzaeg.   

Abstract

In vitro studies have reported that plasmacytoid dendritic cells (PDCs) exert multiple functions, including production of interferon (IFN)-alpha as effector cells and regulation of T-cell responses as mature DCs. Here we review recent data obtained in situ showing that PDCs accumulate in lesions of type I IFN-related disorders (virus infections and lupus erythematosus), Th2 cell-dominated allergic reactions, and ovarian carcinoma. These results demonstrate that PDCs do migrate to peripheral tissues during inflammation, which lends further support to the view that PDCs most likely are important players in innate and adaptive immunity in vivo. Future research should aim at defining the exact pathogenic or defense roles of PDCs in such disorders and determine whether these cells are potential targets for therapeutic intervention in microbial infections, allergy, autoimmunity, or cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480264     DOI: 10.1016/s0198-8859(02)00759-0

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

Review 1.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

2.  Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.

Authors:  Divya Mehta; Charles L Raison; Bobbi J Woolwine; Ebrahim Haroon; Elisabeth B Binder; Andrew H Miller; Jennifer C Felger
Journal:  Brain Behav Immun       Date:  2013-04-25       Impact factor: 7.217

Review 3.  Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.

Authors:  Felipe von Glehn; Leonilda M Santos; Konstantin E Balashov
Journal:  Immunotherapy       Date:  2012-10       Impact factor: 4.196

4.  Toll-like receptors and IFN-alpha: partners in autoimmunity.

Authors:  Marco Colonna
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

5.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

Review 6.  Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

Authors:  Julie Charles; Laurence Chaperot; Dimitri Salameire; Jérémy Di Domizio; Caroline Aspord; Rémy Gressin; Marie-Christine Jacob; Marie-Jeanne Richard; Jean-Claude Beani; Joel Plumas; Marie-Thérèse Leccia
Journal:  Eur J Dermatol       Date:  2009-10-22       Impact factor: 3.328

7.  Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis.

Authors:  Minoru Gotoh; Osamu Kaminuma; Takachika Hiroi; Kimihiro Okubo
Journal:  Allergy Asthma Immunol Res       Date:  2018-09       Impact factor: 5.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.